Stephen Y Chan MD PhD
Professor of Medicine with Tenure, University of Pittsburgh School of Medicine
Join to View Full Profile
200 Lothrop St# E1240Pittsburgh, PA 15213
Phone+1 412-383-6990
Dr. Chan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Massachusetts General HospitalFellowship, Cardiovascular Disease, 2005 - 2009
Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2003 - 2005
University of California San Francisco School of MedicineClass of 2003
Certifications & Licensure
PA State Medical License 2015 - 2026
MA State Medical License 2005 - 2017
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Effectiveness of a Novel Global Telemedicine Curriculum for Medical Students.Pranav Doshi, Anna K Donovan, Erin J Kim, Meghan Moretti, Stephen Y Chan
Journal of General Internal Medicine. 2025-02-01 - 2 citationsLysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertension.Lloyd D Harvey, Mona Alotaibi, Yi-Yin Tai, Ying Tang, Hee-Jung J Kim
Science. 2025-01-24 - Reversal of inflammatory reprogramming by vasodilator agents in pulmonary hypertension.Anna Kirillova, Meena Sethuraman, Xishuang Dong, Almina Kirdar, Gil Speyer
ERJ Open Research. 2025-01-01
Journal Articles
- Sleep Apnea Is Not Associated with Elevations in Pulmonary Artery Pressure in a Clinical CohortMichael V Genuardi, Stephen Y Chan, Sanjay R Patel, Journal of Cardiac Failure
Authored Content
- Sleep Apnea Is Not Associated with Elevations in Pulmonary Artery Pressure in a Clinical CohortAugust 2018
Press Mentions
Pulmonary Arterial Hypertension Associated with CHD: Developments in Treatments, Remaining Gaps According to ExpertsAugust 17th, 2020
Hidden Origins of Pulmonary Hypertension Revealed by Network ModelingJune 24th, 2014- Researchers Awarded $15 Million to Study Inflammation’s Impact on Heart, Brain HealthApril 18th, 2024
- Join now to see all
Grant Support
- Genetic and hypoxic control of a lncRNA axis orchestrates endothelial reprogramming in pulmonary hypertensionUNIVERSITY OF PITTSBURGH AT PITTSBURGH2023–2027
- An endothelial-fibroblast axis connecting senescence to amino acid metabolism for control of vascular stiffness in PAHUNIVERSITY OF PITTSBURGH AT PITTSBURGH2014–2026
- Frataxin deficiency as a cause of endothelial senescence in multiple subtypes of pulmonary hypertensionUNIVERSITY OF PITTSBURGH AT PITTSBURGH2015–2025
- Frataxin deficiency as a cause of endothelial senescence in multiple subtypes of pulmonary hypertensionUNIVERSITY OF PITTSBURGH AT PITTSBURGH2015–2025
- Frataxin deficiency as a cause of endothelial senescence in multiple subtypes of pulmonary hypertensionUNIVERSITY OF PITTSBURGH AT PITTSBURGH2015–2025
- Frataxin deficiency as a cause of endothelial senescence in multiple subtypes of pulmonary hypertensionUNIVERSITY OF PITTSBURGH AT PITTSBURGH2015–2025
- Frataxin deficiency as a cause of endothelial senescence in multiple subtypes of pulmonary hypertensionUNIVERSITY OF PITTSBURGH AT PITTSBURGH2015–2025
- Functions Of The Hypoxia-Induced Microrna-210 In Pulmonary Vascular EndotheliumNational Heart, Lung, And Blood Institute2010–2012
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
